Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-10-23

FDA Approved: ACANYA — Original Application (Bausch Health US, LLC)

View source ↗

Summary

FDA approves ACANYA, a fixed-dose topical combination of clindamycin phosphate and benzoyl peroxide, based on the original NDA from Bausch Health US, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACANYA (CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE)

Snippet

ORIG AP for ACANYA (CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE)